Those New Medicare Rules On Bundling For Dialysis
After much anticipation, the Centers for Medicare & Medicaid Services last night issued its new rules on the bundling payment system for meds used to treat anemia. The bottom line is that after the rules goes into effect, the use of anemia drugs – notably, Amgen’s Epogen – will likely drop, which was expected. But the agency did offer one surprise: some oral meds will be exempt until 2014.
Right now, Medicare pays a set fee for each dialysis treatment, but drugs such as Epogen are reimbursed separately. This sparked controversy because hospitals and clinics had more incentive to use more Epogen, which racked up $2.65 billion in sales last year. But widespread use is not only a big expense for Medicare, but also a concern ever since studies found such drugs were linked to heart …
Go to Source